Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Rpx Corp (RPXC): Mangrove Partners Raises Stake to 7.2%

Page 1 of 10

In a recently-amended 13D filing with the Securities and Exchange Commission, Nathaniel August‘s Mangrove Partners Master Fund, Ltd. reported increasing its stake in Rpx Corp (NASDAQ:RPXC) to 3.59 million common shares, which amass 7.2% of the company’s outstanding stock. Previously, the fund’s stake consisted of 3.53 million common shares, as per its 13F filing for the reporting period of June 30.

RPX Corporation is a provider of patent risk management solutions that offer a variety of professional services to customers in the areas of acquisition syndication, defensive buying, advisory, and patent intelligence. Over the past 12 months, the company’s stock has lost 29.64%. For the second quarter of 2016, the company disclosed earnings per share of $0.18 and revenue of $83.11 million, both beating analysts’ estimates of $0.13 for EPS, and $82.14 million for revenue.

Nathaniel August - Mangrove Partners

According to our hedge fund database, investors long Rpx (NASDAQ:RPXC) at the end of June included Jim Simons’ Renaissance Technologies, with a position valued at $18.80 million, Chuck Royce’s Royce & Associates, with a $4.21 million position, Joshua Packwood and Schuster Tanger’s Radix Partners, and Matthew Tewksbury’s Stevens Capital Management.

Some of the smart money managers who initiated new positions in the stock during the second quarter included Ari Zweiman’s 683 Capital Partners, which had $6.42 million invested in the company at the end of June, Ken Griffin’s Citadel Investment Group, which acquired a $232,000 position, and Neil Chriss’ Hutchin Hill Capital. An investor who decided to dump Rpx (NASDAQ:RPXC) during the quarter was George Hall’s Clinton Group, which said goodbye to the $455,000 worth of stock that it had held on March 31.

Follow Rpx Corp (NASDAQ:RPXC)
Trade (NASDAQ:RPXC) Now!

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
The Mangrove Partners Master Fund, Ltd 0 3,592,314 0 3,592,314 3,592,314 7.2%
The Mangrove Partners Fund 0 3,592,314 0 3,592,314 3,592,314 7.2%
The Mangrove Partners Fund (Cayman), Ltd 0 3,592,314 0 3,592,314 3,592,314 7.2%
Mangrove Partners 0 3,592,314 0 3,592,314 3,592,314 7.2%
Mangrove Capital 0 3,592,314 0 3,592,314 3,592,314 7.2%
Nathaniel August 0 3,592,314 0 3,592,314 3,592,314 7.2%
Nathaniel August
Nathaniel August
Mangrove Partners

Page 1 of 10 – SEC Filing

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
(RULE 13D – 101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a)
(Amendment No. 3)*
RPX Corporation
(Name of Issuer)
Common Stock, $0.0001 par value
(Title of Class of Securities)
74972G103
(CUSIP Number)
Christopher P. Davis, Esq.
Kleinberg, Kaplan, Wolff & Cohen, P.C.
551 Fifth Avenue, New York, New York 10176
Tel:  (212) 986-6000
 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
August 5, 2016
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [  ].
Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Page 1 of 10

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!